Cumberland Pharmaceuticals, Inc. (CPIX) Misses Q4 EPS by 1c

Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q4 EPS of $0.04, $0.01 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $13 million versus the consensus estimate of $12.97 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• Zillow Group (ZG) PT Lowered to $53 at BofA Securities
• Novartis (NVS) PT Raised to $108 at CFRA